Is there any robust evidence showing that SGLT2 inhibitor predisposes to cancer?
Sidar CopurAbdullah Burak YildizAdrian CovicMehmet KanbayPublished in: European journal of clinical investigation (2023)
More large-scale pre-clinical and clinical studies are needed to explore their potential preventive and therapeutic roles of SGLT-2 inhibitors in cancer treatment. In this narrative review, our aim is to explore the pre-clinical and clinical data regarding the potential anti-cancer effects of SGLT-2 inhibitors including the hypothetical pathophysiological mechanisms.